Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program.

Published in: International journal of pediatric endocrinology (2020)

This trial was sponsored by Novo Nordisk and is registered with ClinicalTrials.gov (NCT01009905). Registered November 11, 2009; retrospectively registered.

Keyphrases

growth hormone
young adults
body mass index
clinical trial
study protocol
quality improvement
phase iii
phase ii
big data
randomized controlled trial
stem cells
replacement therapy
metabolic syndrome
mesenchymal stem cells
cell therapy
bone marrow
smoking cessation
glycemic control
insulin resistance